GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » Short-Term Debt

Sartorius AG (Sartorius AG) Short-Term Debt : $329 Mil (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Sartorius AG Short-Term Debt?

Sartorius AG's Short-Term Debt for the quarter that ended in Mar. 2024 was $329 Mil.

Sartorius AG's quarterly Short-Term Debt declined from Sep. 2023 ($312 Mil) to Dec. 2023 ($278 Mil) but then increased from Dec. 2023 ($278 Mil) to Mar. 2024 ($329 Mil).

Sartorius AG's annual Short-Term Debt increased from Dec. 2021 ($352 Mil) to Dec. 2022 ($555 Mil) but then declined from Dec. 2022 ($555 Mil) to Dec. 2023 ($278 Mil).

Sartorius AG Short-Term Debt Historical Data

The historical data trend for Sartorius AG's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Short-Term Debt Chart

Sartorius AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 187.71 213.43 351.75 554.87 277.86

Sartorius AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 350.43 498.70 311.95 277.86 329.35

Sartorius AG Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Sartorius AG Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG (Sartorius AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (OTCPK:SARTF) » Definitions » Short-Term Debt
Comparable Companies
MIL:SFL ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543 XSWX:STMN BAX COO HOLX TSE:7733 XTER:AFX TSE:6869 TFX SZSE:300896
Traded in Other Exchanges
SOAGY:USA SSSGY:USA SUVPF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Germany SRT3:Austria
Address
Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079
Website
https://www.sartorius.com
Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.